[{"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-001", "question": "A 4-year-old boy presents with recurrent bacterial infections since infancy, including pneumonia and otitis media. Laboratory evaluation reveals absent CD19+ B cells, normal T cell numbers with preserved proliferation to mitogens, and undetectable serum immunoglobulins. Genetic testing identifies a mutation in a cytoplasmic tyrosine kinase essential for B cell development. His 2-year-old brother is asymptomatic but has the same mutation. Which of the following best explains the brother's lack of clinical manifestations?", "options": ["Residual maternal IgG providing passive immunity", "Somatic mosaicism with partial gene function restoration", "Compensatory upregulation of alternative signaling pathways", "X-chromosome inactivation favoring the wild-type allele", "Presence of a hypomorphic rather than null mutation"], "answer": "A", "answer_index": 0, "explanation": "This case describes X-linked agammaglobulinemia (XLA) due to BTK mutation. At age 2, the asymptomatic brother may still have residual transplacentally acquired maternal IgG, which typically wanes by 6-9 months but can persist longer in some cases, providing temporary protection. X-chromosome inactivation is irrelevant as this is an X-linked recessive condition affecting males who have only one X chromosome. Somatic mosaicism and hypomorphic mutations would show some B cell development, which is absent here.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (A) is not the single best answer. The vignette describes classic X-linked agammaglobulinemia (XLA) due to a BTK mutation, with absent B cells and immunoglobulins. The asymptomatic 2-year-old brother has the same mutation. While residual maternal IgG (A) is a possible explanation, it is highly unlikely to provide protection until age 2, as it typically wanes by 6-9 months. The most plausible and best-supported explanation is a hypomorphic mutation (E), which can cause a milder, later-onset phenotype, consistent with preserved genetic testing but variable clinical expressivity. Options B, C, and D are less likely given the provided lab findings. The main logical issue is the key mismatch. Minimal fix: Change the correct answer key to E.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":", "judge_output_valid": false, "judge_parse_error": "json decode error: Expecting value: line 5 column 30 (char 926)"}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-002", "question": "A 58-year-old woman with metastatic melanoma receiving combination ipilimumab and nivolumab develops acute onset confusion, fever to 39.2°C, and neck stiffness on day 21 of treatment. CSF analysis shows 180 WBC/μL (92% lymphocytes), protein 156 mg/dL, glucose 52 mg/dL (serum 98 mg/dL), and negative Gram stain. MRI brain shows leptomeningeal enhancement. CSF cytology and flow cytometry are negative for malignant cells. Which additional CSF finding would most strongly support the diagnosis of immune checkpoint inhibitor-induced aseptic meningitis over infectious or neoplastic etiologies?", "options": ["Elevated CSF adenosine deaminase level", "Presence of oligoclonal bands with matched serum bands", "Markedly elevated CSF IL-17 levels", "CD4+/CD8+ T cell ratio greater than 4:1 with activated phenotype", "Elevated CSF beta-2 microglobulin"], "answer": "D", "answer_index": 3, "explanation": "Immune checkpoint inhibitor-induced aseptic meningitis characteristically shows a CD4+ predominant lymphocytic pleocytosis with activated T cell phenotype (expressing HLA-DR, CD69), reflecting the mechanism of enhanced T cell activation. Elevated ADA suggests tuberculosis; oligoclonal bands suggest MS or infectious processes; elevated IL-17 is nonspecific; beta-2 microglobulin elevation occurs in lymphomatous meningitis. The CD4+/CD8+ ratio with activation markers specifically reflects the immunologic mechanism of checkpoint inhibitor toxicity.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: patient on ipilimumab/nivolumab with acute meningitis symptoms, lymphocytic pleocytosis, negative cytology/flow, and leptomeningeal enhancement. The question asks for the CSF finding that most strongly supports immune-related meningitis over infectious/neoplastic causes. The keyed answer (D) describes a CD4+/CD8+ ratio >4:1 with activated phenotype. However, while immune-related meningitis can show a lymphocytic predominance, a CD4+ predominance with a specific high ratio is not a well-established, pathognomonic diagnostic criterion for this toxicity over other lymphocytic meningitides (e.g., viral, autoimmune). The most specific finding to support an immune-mediated, treatment-related etiology in this context is the presence of matched oligoclonal bands in CSF and serum (B), which is a recognized biomarker of systemic immune activation seen in checkpoint inhibitor-related neurologic toxicities. Option D is not uniquely diagnostic. Main logical issue: a unique best answer exists, but the provided key is not it. Minimal fix: Change the key to B and adjust the rationale to highlight matched oligoclonal bands as a marker of systemic immune activation from checkpoint inhibitors.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \t\n  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: patient on ipilimumab/nivolumab with acute meningitis symptoms, lymphocytic pleocytosis, negative cytology/flow, and leptomeningeal enhancement. The question asks for the CSF finding that most strongly supports immune-related meningitis over infectious/neoplastic causes. The keyed answer (D) describes a CD4+/CD8+ ratio >4:1 with activated phenotype. However, while immune-related meningitis can show a lymphocytic predominance, a CD4+ predominance with a specific high ratio is not a well-established, pathognomonic diagnostic criterion for this toxicity over other lymphocytic meningitides (e.g., viral, autoimmune). The most specific finding to support an immune-mediated, treatment-related etiology in this context is the presence of matched oligoclonal bands in CSF and serum (B), which is a recognized biomarker of systemic immune activation seen in checkpoint inhibitor-related neurologic toxicities. Option D is not uniquely diagnostic. Main logical issue: a unique best answer exists, but the provided key is not it. Minimal fix: Change the key to B and adjust the rationale to highlight matched oligoclonal bands as a marker of systemic immune activation from checkpoint inhibitors.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-003", "question": "A 6-month-old infant presents with progressive hypotonia, poor feeding, and developmental regression over 2 weeks. Parents report a recent upper respiratory infection. Examination reveals absent deep tendon reflexes, tongue fasciculations, and paradoxical breathing. EMG shows fibrillation potentials and reduced motor unit recruitment. Genetic testing for SMN1 deletions is negative. CSF protein is markedly elevated at 280 mg/dL. Which of the following is the most likely diagnosis?", "options": ["Infantile-onset Pompe disease", "Acute motor axonal neuropathy variant of Guillain-Barré syndrome", "Spinal muscular atrophy type 1 with atypical genetics", "Infantile botulism", "Cytomegalovirus-associated polyradiculopathy"], "answer": "B", "answer_index": 1, "explanation": "The combination of acute/subacute onset following infection, areflexia, tongue fasciculations (cranial nerve involvement), paradoxical breathing, EMG showing denervation, and markedly elevated CSF protein with albuminocytologic dissociation strongly suggests acute motor axonal neuropathy (AMAN), a GBS variant. SMA type 1 would have positive SMN1 testing in >95% of cases and insidious onset. Infantile botulism shows decremental response on repetitive stimulation and normal CSF. Pompe disease shows myopathic EMG changes. CMV polyradiculopathy typically occurs in immunocompromised patients.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: acute onset post-URI, areflexia, tongue fasciculations, paradoxical breathing, denervation on EMG, markedly elevated CSF protein, and negative SMN1 testing. These strongly point to a motor neuronopathy or polyradiculopathy. The keyed answer (B, AMAN) is incorrect because AMAN is a pure motor axonal neuropathy; it does not cause tongue fasciculations (a sign of lower motor neuron denervation) or fibrillation potentials on EMG (which indicate acute denervation). These features, combined with the elevated CSF protein, are classic for poliomyelitis or a similar enteroviral motor neuron disease, which is not listed. Option C (SMA) is ruled out by negative genetics and acute onset. Options A, D, and E are inconsistent with EMG or CSF findings. The item has a unique best answer based on the findings, but it is not among the provided options, making the key incorrect. Minimal fix: Replace the keyed answer with the correct diagnosis implied by the findings (e.g., 'Poliomyelitis' or 'Enteroviral motor neuronitis') or adjust the stem to remove findings inconsistent with GBS (e.g., remove tongue fasciculations).\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: acute onset post-URI, areflexia, tongue fasciculations, paradoxical breathing, denervation on EMG, markedly elevated CSF protein, and negative SMN1 testing. These strongly point to a motor neuronopathy or polyradiculopathy. The keyed answer (B, AMAN) is incorrect because AMAN is a pure motor axonal neuropathy; it does not cause tongue fasciculations (a sign of lower motor neuron denervation) or fibrillation potentials on EMG (which indicate acute denervation). These features, combined with the elevated CSF protein, are classic for poliomyelitis or a similar enteroviral motor neuron disease, which is not listed. Option C (SMA) is ruled out by negative genetics and acute onset. Options A, D, and E are inconsistent with EMG or CSF findings. The item has a unique best answer based on the findings, but it is not among the provided options, making the key incorrect. Minimal fix: Replace the keyed answer with the correct diagnosis implied by the findings (e.g., 'Poliomyelitis' or 'Enteroviral motor neuronitis') or adjust the stem to remove findings inconsistent with GBS (e.g., remove tongue fasciculations).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-004", "question": "A 45-year-old man with acute myeloid leukemia undergoes allogeneic hematopoietic stem cell transplantation. On day +14, he develops fever, hypoxemia, and diffuse pulmonary infiltrates. Bronchoalveolar lavage shows hemorrhagic return with progressively bloodier aliquots. DAD is seen on transbronchial biopsy. Galactomannan, beta-D-glucan, and respiratory viral panel are negative. He is on tacrolimus with therapeutic levels. Which of the following findings would most strongly support a diagnosis of diffuse alveolar hemorrhage due to transplant-associated thrombotic microangiopathy rather than idiopathic pneumonia syndrome?", "options": ["Elevated serum lactate dehydrogenase with schistocytes on peripheral smear", "Presence of hemosiderin-laden macrophages in BAL fluid", "Concurrent acute kidney injury with proteinuria", "Elevated plasma-free hemoglobin with decreased haptoglobin", "Refractory thrombocytopenia despite platelet transfusions"], "answer": "E", "answer_index": 4, "explanation": "Transplant-associated thrombotic microangiopathy (TA-TMA) characteristically shows refractory thrombocytopenia that fails to increment appropriately with platelet transfusions due to ongoing platelet consumption in microthrombi. While elevated LDH, schistocytes, and decreased haptoglobin occur in both TA-TMA and other hemolytic processes, and AKI can occur in multiple post-transplant complications, the specific finding of platelet refractoriness distinguishes TA-TMA. Hemosiderin-laden macrophages simply confirm alveolar hemorrhage without indicating etiology. Idiopathic pneumonia syndrome does not cause platelet refractoriness.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: post-alloHSCT day +14, fever/hypoxemia/infiltrates, hemorrhagic BAL with bloodier aliquots, DAD on biopsy, negative infectious workup, therapeutic tacrolimus. The question asks for the finding most specific for TA-TMA over IPS. The keyed answer (E, refractory thrombocytopenia) is a recognized feature of TA-TMA, but it is not the most specific or strongest discriminator. Option A (elevated LDH with schistocytes) is the hallmark laboratory finding for thrombotic microangiopathy (TMA) and is a more direct and specific indicator of the underlying microangiopathic hemolytic process causing TA-TMA than platelet refractoriness alone. Platelet refractoriness can have other causes post-transplant (e.g., alloimmunization). The item's logic is medically plausible but prioritizes a supportive feature over a pathognomonic one. Minimal fix: Change the key to A, or rephrase the stem to ask for a 'supportive' rather than 'most strongly support' finding for TA-TMA.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"4\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: post-alloHSCT day +14, fever/hypoxemia/infiltrates, hemorrhagic BAL with bloodier aliquots, DAD on biopsy, negative infectious workup, therapeutic tacrolimus. The question asks for the finding most specific for TA-TMA over IPS. The keyed answer (E, refractory thrombocytopenia) is a recognized feature of TA-TMA, but it is not the most specific or strongest discriminator. Option A (elevated LDH with schistocytes) is the hallmark laboratory finding for thrombotic microangiopathy (TMA) and is a more direct and specific indicator of the underlying microangiopathic hemolytic process causing TA-TMA than platelet refractoriness alone. Platelet refractoriness can have other causes post-transplant (e.g., alloimmunization). The item's logic is medically plausible but prioritizes a supportive feature over a pathognomonic one. Minimal fix: Change the key to A, or rephrase the stem to ask for a 'supportive' rather than 'most strongly support' finding for TA-TMA.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-005", "question": "A 3-year-old girl presents with acute onset right-sided weakness and slurred speech. CT head is negative for hemorrhage. MRI reveals acute left middle cerebral artery territory infarction. Echocardiogram shows no structural abnormalities or vegetations. Hypercoagulability workup including protein C, protein S, antithrombin III, factor V Leiden, and prothrombin gene mutation are normal. Hemoglobin electrophoresis is normal. She had chickenpox 6 weeks ago. Cerebral angiography shows focal stenosis of the left distal internal carotid artery with a \"beaded\" appearance. Which of the following is the most appropriate long-term management?", "options": ["Lifelong warfarin anticoagulation", "Aspirin therapy for 2 years with serial vascular imaging", "Immediate surgical bypass of the stenotic segment", "High-dose intravenous immunoglobulin monthly", "Indefinite dual antiplatelet therapy with aspirin and clopidogrel"], "answer": "B", "answer_index": 1, "explanation": "This presentation is classic for post-varicella arteriopathy (transient cerebral arteriopathy), which causes focal stenosis of large intracranial arteries following VZV infection. The condition is typically monophasic and self-limiting, with arterial changes stabilizing or improving over 6-24 months. Current guidelines recommend aspirin therapy for approximately 2 years with serial vascular imaging to monitor for progression or resolution. Anticoagulation is not superior to antiplatelet therapy and carries higher bleeding risk. Surgical bypass is not indicated for this typically self-resolving condition. IVIG has no established role in post-varicella arteriopathy.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: 3-year-old with acute MCA stroke, recent chickenpox (6 weeks), angiography showing focal distal ICA stenosis with 'beaded' appearance, negative workup for other causes. This pattern is classic for post-varicella arteriopathy (transient cerebral arteriopathy). The condition is typically monophasic and self-limiting. Main logical issue: None; the vignette provides sufficient specific findings to point to this diagnosis. Main medical accuracy issue: None; the keyed answer aligns with current pediatric stroke guidelines for this condition. Minimal fix: None required; the item is clear and accurate. The rationale correctly explains why antiplatelet therapy for a limited duration with monitoring is preferred over anticoagulation, surgery, or IVIG.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: 3-year-old with acute MCA stroke, recent chickenpox (6 weeks), angiography showing focal distal ICA stenosis with 'beaded' appearance, negative workup for other causes. This pattern is classic for post-varicella arteriopathy (transient cerebral arteriopathy). The condition is typically monophasic and self-limiting. Main logical issue: None; the vignette provides sufficient specific findings to point to this diagnosis. Main medical accuracy issue: None; the keyed answer aligns with current pediatric stroke guidelines for this condition. Minimal fix: None required; the item is clear and accurate. The rationale correctly explains why antiplatelet therapy for a limited duration with monitoring is preferred over anticoagulation, surgery, or IVIG.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-006", "question": "A 62-year-old man with small cell lung cancer develops progressive proximal weakness over 3 months. He has difficulty rising from chairs and climbing stairs. Examination reveals proximal muscle weakness (3/5), preserved reflexes, and no sensory deficits. CK is 4,200 U/L. EMG shows myopathic changes with fibrillation potentials. Muscle biopsy reveals necrotic and regenerating fibers with minimal inflammatory infiltrate. Testing for anti-Jo-1, anti-Mi-2, anti-SRP, and anti-MDA5 antibodies is negative. Which antibody is most likely to be positive in this patient?", "options": ["Anti-HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase)", "Anti-TIF1-gamma (transcription intermediary factor 1-gamma)", "Anti-NXP-2 (nuclear matrix protein 2)", "Anti-SAE (small ubiquitin-like modifier activating enzyme)", "Anti-HMGCR antibodies with concurrent anti-SRP positivity"], "answer": "B", "answer_index": 1, "explanation": "Anti-TIF1-gamma antibodies are strongly associated with malignancy-associated dermatomyositis/inflammatory myopathy, particularly in adults over 40 with underlying cancer. Small cell lung cancer is a known associated malignancy. The biopsy showing necrotizing features with minimal inflammation is consistent with immune-mediated necrotizing myopathy, which can occur with TIF1-gamma positivity in cancer-associated cases. Anti-HMGCR is associated with statin exposure and necrotizing myopathy but not specifically with malignancy. Anti-NXP-2 is associated with calcinosis and juvenile dermatomyositis. Anti-SAE is associated with dermatomyositis with systemic features but lower malignancy risk.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Proximal weakness, high CK, EMG myopathic changes, biopsy showing necrotic fibers with minimal inflammation, and negative for common myositis antibodies (anti-Jo-1, Mi-2, SRP, MDA5). The clinical picture is classic for immune-mediated necrotizing myopathy (IMNM). The most likely antibody in this cancer-associated IMNM, given the negative anti-SRP, is anti-HMGCR, which is strongly linked to paraneoplastic necrotizing myopathy, especially in older adults. Anti-TIF1-gamma is associated with cancer-associated dermatomyositis, which typically features skin rash and perifascicular atrophy on biopsy, neither present here. Main logical issue: The keyed answer (B) does not match the single best answer (A) supported by the vignette. Main medical accuracy issue: The rationale incorrectly states anti-TIF1-gamma is consistent with a necrotizing biopsy pattern; it is classically linked to dermatomyositis pathology. Minimal fix: Change the correct answer key to A (Anti-HMGCR).\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict on keyed answer: Miskeyed. Key stem clues: Proximal weakness, high CK, EMG myopathic changes, biopsy showing necrotic fibers with minimal inflammation, and negative for common myositis antibodies (anti-Jo-1, Mi-2, SRP, MDA5). The clinical picture is classic for immune-mediated necrotizing myopathy (IMNM). The most likely antibody in this cancer-associated IMNM, given the negative anti-SRP, is anti-HMGCR, which is strongly linked to paraneoplastic necrotizing myopathy, especially in older adults. Anti-TIF1-gamma is associated with cancer-associated dermatomyositis, which typically features skin rash and perifascicular atrophy on biopsy, neither present here. Main logical issue: The keyed answer (B) does not match the single best answer (A) supported by the vignette. Main medical accuracy issue: The rationale incorrectly states anti-TIF1-gamma is consistent with a necrotizing biopsy pattern; it is classically linked to dermatomyositis pathology. Minimal fix: Change the correct answer key to A (Anti-HMGCR).", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-007", "question": "A 28-year-old woman at 32 weeks gestation presents with severe headache, visual changes, and right upper quadrant pain. Blood pressure is 178/112 mmHg. Laboratory studies show platelets 62,000/μL, AST 342 U/L, ALT 298 U/L, LDH 890 U/L, creatinine 1.8 mg/dL, and peripheral smear with schistocytes. Urinalysis shows 3+ protein. She receives magnesium sulfate and labetalol. Despite delivery 6 hours later, her platelet count drops to 28,000/μL and creatinine rises to 3.2 mg/dL over the next 48 hours. ADAMTS13 activity returns at 68%. Which of the following is the most appropriate next step in management?", "options": ["Initiate therapeutic plasma exchange", "Administer eculizumab", "Begin rituximab infusion", "Transfuse platelets to maintain count above 50,000/μL", "Continue supportive care with expectant management"], "answer": "B", "answer_index": 1, "explanation": "This patient has pregnancy-associated atypical hemolytic uremic syndrome (aHUS), evidenced by persistent/worsening microangiopathic hemolytic anemia and renal failure after delivery with ADAMTS13 activity >10% (ruling out TTP). Complement-mediated aHUS can be triggered by pregnancy and does not resolve with delivery alone. Eculizumab, a C5 complement inhibitor, is the treatment of choice for aHUS. Plasma exchange is first-line for TTP (ADAMTS13 <10%) but less effective in aHUS. Rituximab targets B cells and is used for autoimmune TTP. Platelet transfusion is relatively contraindicated in TMA. Expectant management risks progressive renal failure.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Severe preeclampsia/HELLP syndrome presentation at 32 weeks, with persistent/worsening thrombocytopenia and renal failure postpartum. ADAMTS13 activity of 68% rules out TTP. The most likely diagnosis is severe preeclampsia with HELLP syndrome, which can have a protracted postpartum course. The keyed answer (B, eculizumab) is for atypical HUS, a diagnosis not established here. The most appropriate next step for presumed severe preeclampsia/HELLP with worsening renal function postpartum is supportive care (E), including blood pressure control and monitoring, as most cases improve spontaneously. Plasma exchange (A) is not indicated. The item is miskeyed because it forces an aHUS diagnosis without sufficient evidence. Minimal fix: Change the key to E (Continue supportive care) or, to justify eculizumab, explicitly state genetic testing confirms complement dysregulation or that HELLP has been ruled out.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: Severe preeclampsia/HELLP syndrome presentation at 32 weeks, with persistent/worsening thrombocytopenia and renal failure postpartum. ADAMTS13 activity of 68% rules out TTP. The most likely diagnosis is severe preeclampsia with HELLP syndrome, which can have a protracted postpartum course. The keyed answer (B, eculizumab) is for atypical HUS, a diagnosis not established here. The most appropriate next step for presumed severe preeclampsia/HELLP with worsening renal function postpartum is supportive care (E), including blood pressure control and monitoring, as most cases improve spontaneously. Plasma exchange (A) is not indicated. The item is miskeyed because it forces an aHUS diagnosis without sufficient evidence. Minimal fix: Change the key to E (Continue supportive care) or, to justify eculizumab, explicitly state genetic testing confirms complement dysregulation or that HELLP has been ruled out.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-008", "question": "A 14-year-old boy with no significant medical history presents after a witnessed generalized tonic-clonic seizure lasting 2 minutes with spontaneous termination. He reports a 3-month history of early morning myoclonic jerks causing him to drop objects, which he attributed to clumsiness. EEG shows 4-6 Hz generalized polyspike-and-wave discharges with photosensitivity. MRI brain is normal. His father had similar episodes as a teenager that resolved. Which of the following medications should be specifically avoided in this patient?", "options": ["Levetiracetam", "Valproic acid", "Lamotrigine", "Carbamazepine", "Topiramate"], "answer": "D", "answer_index": 3, "explanation": "This patient has juvenile myoclonic epilepsy (JME), characterized by myoclonic jerks (especially morning), generalized tonic-clonic seizures, photosensitivity, and generalized polyspike-and-wave on EEG. Carbamazepine and other sodium channel blockers (phenytoin, oxcarbazepine) can paradoxically worsen myoclonic and absence seizures in genetic generalized epilepsies like JME by enhancing thalamocortical synchronization. Valproic acid is highly effective but avoided in women of childbearing potential due to teratogenicity. Levetiracetam and lamotrigine are appropriate alternatives. Topiramate has broad-spectrum efficacy including in JME.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: V. Verdict: Correct best. Key stem clues: adolescent with morning myoclonic jerks, generalized tonic-clonic seizure, photosensitivity, generalized polyspike-and-wave EEG, normal MRI, and family history. This pattern is classic for juvenile myoclonic epilepsy (JME). In JME, sodium channel blockers like carbamazepine are known to potentially worsen myoclonic and absence seizures, making it the medication to avoid. The other options (levetiracetam, valproic acid, lamotrigine, topiramate) are all considered appropriate broad-spectrum agents for JME. No logical contradictions or missing details are present. Medical accuracy is sound. Minimal fix: None required; the item is clear and accurate as written.\",\n  \"logical_false_reason\": \"T\",\n  \"logical_validity\": true,\n  \"medical_accuracy_score\":  \t\n  \"5\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best. Key stem clues: adolescent with morning myoclonic jerks, generalized tonic-clonic seizure, photosensitivity, generalized polyspike-and-wave EEG, normal MRI, and family history. This pattern is classic for juvenile myoclonic epilepsy (JME). In JME, sodium channel blockers like carbamazepine are known to potentially worsen myoclonic and absence seizures, making it the medication to avoid. The other options (levetiracetam, valproic acid, lamotrigine, topiramate) are all considered appropriate broad-spectrum agents for JME. No logical contradictions or missing details are present. Medical accuracy is sound. Minimal fix: None required; the item is clear and accurate as written.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-009", "question": "A 55-year-old man is admitted to the ICU with septic shock secondary to necrotizing pancreatitis. Despite adequate fluid resuscitation and norepinephrine at 0.5 mcg/kg/min, his MAP remains 58 mmHg. Vasopressin 0.04 units/min is added. Central venous oxygen saturation is 58%, lactate is 6.2 mmol/L, and cardiac index by thermodilution is 2.0 L/min/m². Echocardiogram shows hyperdynamic left ventricle with LVEF 70% and small, underfilled chambers. Which of the following is the most appropriate next intervention?", "options": ["Add dobutamine for inotropic support", "Administer additional crystalloid bolus", "Initiate phenylephrine infusion", "Add epinephrine as third vasopressor", "Begin hydrocortisone 50 mg IV every 6 hours"], "answer": "B", "answer_index": 1, "explanation": "Despite initial resuscitation, the echocardiographic findings of hyperdynamic LV with small, underfilled chambers indicate persistent hypovolemia. The low ScvO2 (58%) and elevated lactate suggest inadequate oxygen delivery. In the setting of distributive shock with evidence of preload deficiency, additional volume resuscitation is indicated before adding further vasopressors. Dobutamine would be inappropriate given the already hyperdynamic state. Phenylephrine causes pure vasoconstriction without inotropy and may worsen cardiac output. Epinephrine could be considered after optimizing preload. Hydrocortisone is indicated for refractory shock but addressing hypovolemia takes priority.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n  \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: septic shock with persistent hypotension (MAP 58) despite norepinephrine and vasopressin; hyperdynamic LV (EF 70%) with small, underfilled chambers; low ScvO2 (58%), high lactate (6.2), low cardiac index (2.0). The echocardiogram suggests hypovolemia, but the low cardiac index and ScvO2 in a hyperdynamic heart indicate a primary problem of inadequate cardiac output despite high contractility, most consistent with a low preload state. However, the keyed answer (B, additional crystalloid) is not the single best next step. The patient is already on two vasopressors; adding fluid in a patient with necrotizing pancreatitis risks worsening third-spacing and abdominal compartment syndrome. The most appropriate next intervention is adding an inotrope like dobutamine (A) to improve cardiac output and oxygen delivery, as supported by Surviving Sepsis guidelines for shock with low ScvO2 and cardiac index despite adequate fluid and vasopressors. Main logical issue: key mismatch. Minimal fix: Change correct answer key to A.\",\n  \"logical_false_reason\": \"K\",\n  \"logical_validity\": false,\n  \"medical_accuracy_score\":  \"2\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. Key stem clues: septic shock with persistent hypotension (MAP 58) despite norepinephrine and vasopressin; hyperdynamic LV (EF 70%) with small, underfilled chambers; low ScvO2 (58%), high lactate (6.2), low cardiac index (2.0). The echocardiogram suggests hypovolemia, but the low cardiac index and ScvO2 in a hyperdynamic heart indicate a primary problem of inadequate cardiac output despite high contractility, most consistent with a low preload state. However, the keyed answer (B, additional crystalloid) is not the single best next step. The patient is already on two vasopressors; adding fluid in a patient with necrotizing pancreatitis risks worsening third-spacing and abdominal compartment syndrome. The most appropriate next intervention is adding an inotrope like dobutamine (A) to improve cardiac output and oxygen delivery, as supported by Surviving Sepsis guidelines for shock with low ScvO2 and cardiac index despite adequate fluid and vasopressors. Main logical issue: key mismatch. Minimal fix: Change correct answer key to A.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125", "question_id": "20251129T135352000Z_claude-opus-4-5-20251101_seed125-010", "question": "A 7-year-old boy presents with 2 weeks of progressive gait instability and tremor. Examination reveals opsoclonus (chaotic, multidirectional saccadic eye movements), myoclonus, and truncal ataxia. MRI brain and spine are normal. CSF shows mild lymphocytic pleocytosis. CT chest/abdomen/pelvis reveals a paraspinal mass. Urine catecholamines are elevated. Tumor resection is planned. Which of the following additional findings would indicate the WORST long-term neurodevelopmental prognosis despite tumor treatment?", "options": ["Presence of anti-Hu antibodies in serum", "CSF oligoclonal bands with elevated IgG index", "Age less than 3 years at symptom onset", "Tumor histology showing neuroblastoma with MYCN amplification", "Delayed initiation of immunotherapy beyond 4 weeks from diagnosis"], "answer": "C", "answer_index": 2, "explanation": "Opsoclonus-myoclonus-ataxia syndrome (OMS) associated with neuroblastoma has variable neurodevelopmental outcomes. Younger age at onset (particularly <3 years) is paradoxically associated with worse long-term cognitive and behavioral outcomes, likely due to the impact of neuroinflammation on the developing brain during critical periods. While MYCN amplification indicates aggressive tumor biology, it does not correlate with neurological outcomes. Anti-Hu antibodies are rare in pediatric OMS. CSF inflammatory markers and treatment delays affect outcomes but age remains the strongest predictor of neurodevelopmental sequelae.", "generator_model": "claude-opus-4-5-20251101", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "judge_model": "deepseek-v3.2", "judge_model_outputs_raw": "{\n    \"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (C) is not the single best answer. The stem asks for the finding indicating the WORST long-term neurodevelopmental prognosis in OMS associated with neuroblastoma. While age <3 years is a known risk factor for worse neurodevelopmental outcomes, option E (delayed initiation of immunotherapy beyond 4 weeks) is a well-established, modifiable predictor of poor neurological outcome in OMS, often emphasized as critical in management guidelines. The provided rationale incorrectly minimizes this. The stem does not contain internal contradictions (C) or make multiple options equally defensible (M), as a unique best answer exists, but the provided key is not it. Minimal fix: Change the key to E and adjust the rationale to reflect that treatment delay is a major, independent prognostic factor for neurodevelopmental outcome.\",\n    \"logical_false_reason\": \"K\",\n    \"logical_validity\": false,\n    \"medical_accuracy_score\":  \"3\"\n}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed. The keyed answer (C) is not the single best answer. The stem asks for the finding indicating the WORST long-term neurodevelopmental prognosis in OMS associated with neuroblastoma. While age <3 years is a known risk factor for worse neurodevelopmental outcomes, option E (delayed initiation of immunotherapy beyond 4 weeks) is a well-established, modifiable predictor of poor neurological outcome in OMS, often emphasized as critical in management guidelines. The provided rationale incorrectly minimizes this. The stem does not contain internal contradictions (C) or make multiple options equally defensible (M), as a unique best answer exists, but the provided key is not it. Minimal fix: Change the key to E and adjust the rationale to reflect that treatment delay is a major, independent prognostic factor for neurodevelopmental outcome.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 3}]